Angene Chemical
Draw
|
Currency :
Home Products

AG0035M4

475207-59-1 | 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide; 4-methylbenzene-1-sulfonic acid

Chemical structure of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide; 4-methylbenzene-1-sulfonic acid, CAS 475207-59-1
AG0035M4
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 475207-59-1
Catalog Number AG0035M4(AGN-PC-00HB7T)
Chemical Name 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide; 4-methylbenzene-1-sulfonic acid
IUPAC Name 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;4-methylbenzenesulfonic acid
InChI InChI=1S/C21H16ClF3N4O3.C7H8O3S/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25;1-6-2-4-7(5-3-6)11(8,9)10/h2-11H,1H3,(H,26,30)(H2,28,29,31);2-5H,1H3,(H,8,9,10)
InChI Key IVDHYUQIDRJSTI-UHFFFAOYSA-N
MDL Number MFCD08235032
Molecular Formula C28H24ClF3N4O6S
Molecular Weight 637.0266
NSC Number 724772
SMILES O=C(NC1=CC=C(OC2=CC(C(NC)=O)=NC=C2)C=C1)NC3=CC=C(Cl)C(C(F)(F)F)=C3.O=S(C4=CC=C(C)C=C4)(O)=O
UNII 5T62Q3B36J
Synonyms
4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxylic acid methyamide-4-methylbenzenesulfonate, BAY 43 9006, BAY 43-9006, BAY 439006, BAY 545 9085, BAY 545-9085, BAY 5459085, BAY 673472, BAY-545-9085, BAY-673472, BAY5459085, Nexavar, sorafenib, Sorafenib N Oxide, sorafenib N-oxide, sorafenib tosylate, Sorafenib tosylate, 475207-59-1, Nexavar, BAY 43-9006, Nexavar(R), Sorafenib (Tosylate), Sorafenib tosylate [USAN], UNII-5T62Q3B36J, CHEBI:50928, 5T62Q3B36J, BAY 54-9085, AK162385, Sorafenib (Nexavar), Sorafenib tosylate (USAN), DSSTox_CID_27817, DSSTox_RID_82581, DSSTox_GSID_47839, 1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)urea mono(4-methylbenzenesulfonate), 2-Pyridinecarboxamide, 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-, mono(4-methylbenzenesulfonate), 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide 4-methylbenzenesulfonate, 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N2-methylpyridine-2-carboxamide mono (4-methylbenzenesulfonate), 4-methylbenzolsulfons, CAS-475207-59-1, NSC-724772, BAY-54-9085, NCGC00167488-01, SR-00000000529, BAY43-9006 mono-p-tosylate, Sorafenib-Tosylate, BAY 43-9006 mono-p-tosylate, 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;4-methylbenzenesulfonic acid, Nexavar (TN), NSC724772, Sorafenib - Nexavar, Sorafenib TsOH salt, PubChem22488, AC1L8QVY, AC1Q5GRN, Sorafenib tosilate (JAN), BAY 43-9006 tosylate, C28H24ClF3N4O6S, MLS002415564, CHEMBL1200485, DTXSID9047839, Sorafenib (BAY-43-9006), IVDHYUQIDRJSTI-UHFFFAOYSA-N, HMS2219E08, HMS3654I09, Sorafenib, p-Toluenesulfonate salt, AOB87366, KS-000006NB, Tox21_112489, ABP000935, HY-10201A, MFCD08235032, s1040, AKOS015924650, AKOS027469919, Sorafenib Tosylate(Bay 43-9006)/, Tox21_112489_1, AC-6799, CCG-208000, CS-0164, ND-0228, RL03773, NCGC00167488-08, para-toluene sulfonate sorafenib tosylate, AT-17079, Q812, SMR001339079, BCP0726000112, AB0044027, LS-186598, AM20090612, FT-0650737, FT-0698449, ST24049296, SW202562-3, EC-000.2356, A20368, D06272, Q-1222, S-8502, 207S591, A819449, Q-201729, SR-00000000529-5, 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide tosylate, 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide 4-methylbenzenesulfonate, 4-[4-[[[4-chloro-3-(trifluoromethyl)anilino]-oxomethyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide; 4-methylbenzenesulfonic acid, 4-[4-[[4-chloranyl-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide; 4-methylbenzenesulfonic acid, 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide; 4-methylbenzenesulfonic acid, 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)-amino]phenoxy}-N-methylpyridine-2-carboxamide tosylate, 4-{4-[({[4-Chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N -methylpyridine-2-carboxamide tosylate, 4-{4-[({[4-Chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide tosylate, 4-{4-[3-(4-Chloro-3-trifluoromethyl-phenyl)-ureido]-phenoxy} -pyridine-2-carboxylic acid methylamide-4-methylbenzenesulfonate, 4-{4-[3-(4-Cl-3-trifluoromethyl-phenyl)-ureido]-phenoxy}-pyridine-2-carboxylic acid methylamide 4-methylbenzenesulfonate, Sorafenib, Xarelto, Sorafenib Mesylate, cc-333, 4-(Difluoromethoxy)benzoic acid, 475207-59-1 (tosylate), AR-1G3585, CID406563, Sorafenib tosylate, 99% - 1G 1g, ACN-034359, BAY43-9006, CS-O-31023, A10001, C21-H16-Cl-F3-N4-O3.C7-H8-O3-S, 2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-, 4-methylbenzenesulfonate (1:1), 284461-73-0, 4837-20-1, -(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N2-methylpyridine-2-carboxamide mono (4-methylbenzenesulfonate), 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited